CANMAT guidelines for bipolar disorder: A commentary from South America

Bipolar Disorders, Supplement

Volumn 7, Issue 3, 2005, Pages 87-88

  Kapczinski, Flávio ^a,c   Gentil, Valentim ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; LITHIUM; MOCLOBEMIDE; TRANYLCYPROMINE; VALPROATE SEMISODIUM;

BEHAVIOR THERAPY; BIPOLAR DISORDER; CANADA; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HEALTH CARE QUALITY; HUMAN; MEDICAL PROFESSION; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PSYCHOTHERAPY; RISK BENEFIT ANALYSIS; SOUTH AMERICA;

EID: 23044475921     PISSN: 13992406     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2005.00224.x     Document Type: Note

References (1)

1. Kapczinski F (Invited Editor). Evidence-based clinical guidelines for treating bipolar disorder. Revista de psiquiatria clínica, 2005; 32 (Suppl. 1): 3.